Corporate News 24-Aug-23
Gland Pharma's Dundigal unit receives Establishment Inspection Report from USFDA
Gland Pharma announced that following the ‘Good Manufacturing Practice (GMP) Inspection' by US FDA at the Company's Dundigal Facility at Hyderabad between 03 July 2023 and 14 July 2023; the Company has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection.
Previous News
Gland Pharma tumbles after Q4 PAT declines over 72% YoY
( Hot Pursuit - 19-May-23 09:37 )
Gland Pharma's Pashamylaram unit undergoes USFDA audit
( Corporate News - 27-Jun-23 19:30 )
Gland Pharma Ltd gains for fifth session
( Hot Pursuit - 05-Feb-24 13:00 )
Gland Pharma Hyderabad facility gets one USFDA observation
( Hot Pursuit - 28-Jun-23 09:38 )
Gland Pharma Ltd gains for fifth session
( Hot Pursuit - 11-Jun-24 13:00 )
US FDA conducts pre-market inspection at Gland Pharma's Dundigal facility
( Hot Pursuit - 26-Aug-22 09:25 )
Gland Pharma consolidated net profit declines 72.48% in the March 2023 quarter
( Results - Announcements 19-May-23 07:25 )
Gland Pharma receives US FDA nod for immunostimulant Plerixafor
( Hot Pursuit - 07-May-24 12:21 )
Volumes jump at Gland Pharma Ltd counter
( Hot Pursuit - 27-Oct-22 14:30 )
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
( Corporate News - 27-Jan-23 15:26 )
Gland Pharma Ltd leads losers in 'A' group
( Hot Pursuit - 27-Oct-22 15:00 )
Other Stories
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Akme Fintrade (India) to announce Quarterly Result
03-Jul-24 17:43
Ponni Sugars (Erode) to hold board meeting
03-Jul-24 17:43
Aditya Vision to conduct AGM
03-Jul-24 17:43
Back
Top
